COINOTAG recommends • Exchange signup |
💹 Trade with pro tools |
Fast execution, robust charts, clean risk controls. |
👉 Open account → |
COINOTAG recommends • Exchange signup |
🚀 Smooth orders, clear control |
Advanced order types and market depth in one view. |
👉 Create account → |
COINOTAG recommends • Exchange signup |
📈 Clarity in volatile markets |
Plan entries & exits, manage positions with discipline. |
👉 Sign up → |
COINOTAG recommends • Exchange signup |
⚡ Speed, depth, reliability |
Execute confidently when timing matters. |
👉 Open account → |
COINOTAG recommends • Exchange signup |
🧭 A focused workflow for traders |
Alerts, watchlists, and a repeatable process. |
👉 Get started → |
COINOTAG recommends • Exchange signup |
✅ Data‑driven decisions |
Focus on process—not noise. |
👉 Sign up → |
- Biotech stocks are making a comeback in May after a slump in April, with the industry group having a Relative Strength Rating of 86.
- Key biotech stocks to watch include Neurocrine Biosciences, United Therapeutics, CervoMed, Gyre Therapeutics, and Halozyme Therapeutics.
- These companies are making strides in areas such as neuroscience, chronic diseases, neurodegenerative diseases, liver fibrosis, and drug delivery.
Explore the latest developments in the biotech sector, with a focus on key stocks making strides in neuroscience, chronic diseases, neurodegenerative diseases, liver fibrosis, and drug delivery.
Neurocrine Biosciences: Leading in Neuroscience
Neurocrine Biosciences continues to dominate the biotech sector as a leader in the neuroscience space. The company recently sought FDA approval for crinecerfont, a treatment for congenital adrenal hyperplasia. Neurocrine is also testing treatments for schizophrenia and cognitive impairment tied to schizophrenia, with midstage test results expected in the third quarter.
United Therapeutics: Focusing on Chronic Diseases
United Therapeutics is making waves with its treatments for chronic diseases. The company’s drug, Tyvaso, a treatment for pulmonary arterial hypertension, saw a 56% surge in sales in the March quarter. United Therapeutics is also working on a pipeline of treatments, with results of a final-phase PAH study expected in 2026.
CervoMed: Tackling Neurodegenerative Diseases
CervoMed, previously known as EIP Pharma, is a clinical-stage biotech company working on treatments for neurodegenerative diseases. The company’s leading drug is in testing for patients with dementias, including Lewy body dementia and Alzheimer’s disease.
COINOTAG recommends • Professional traders group |
💎 Join a professional trading community |
Work with senior traders, research‑backed setups, and risk‑first frameworks. |
👉 Join the group → |
COINOTAG recommends • Professional traders group |
📊 Transparent performance, real process |
Spot strategies with documented months of triple‑digit runs during strong trends; futures plans use defined R:R and sizing. |
👉 Get access → |
COINOTAG recommends • Professional traders group |
🧭 Research → Plan → Execute |
Daily levels, watchlists, and post‑trade reviews to build consistency. |
👉 Join now → |
COINOTAG recommends • Professional traders group |
🛡️ Risk comes first |
Sizing methods, invalidation rules, and R‑multiples baked into every plan. |
👉 Start today → |
COINOTAG recommends • Professional traders group |
🧠 Learn the “why” behind each trade |
Live breakdowns, playbooks, and framework‑first education. |
👉 Join the group → |
COINOTAG recommends • Professional traders group |
🚀 Insider • APEX • INNER CIRCLE |
Choose the depth you need—tools, coaching, and member rooms. |
👉 Explore tiers → |
Gyre Therapeutics: Addressing Liver Fibrosis
Gyre Therapeutics is working on a drug to treat liver fibrosis due to hepatitis B and metabolic dysfunction-associated steatohepatitis. The company is also considering treatments for chronic obstructive pulmonary disease and pulmonary arterial hypertension.
Halozyme Therapeutics: Expert in Drug Delivery
Halozyme Therapeutics is known for its Enhanze technology, which helps deliver drugs under the skin via a subcutaneous injection. The technology is behind some of the biggest medicines on the market, including Johnson & Johnson’s Darzalex Faspro and Roche’s Herceptin.
COINOTAG recommends • Exchange signup |
📈 Clear interface, precise orders |
Sharp entries & exits with actionable alerts. |
👉 Create free account → |
COINOTAG recommends • Exchange signup |
🧠 Smarter tools. Better decisions. |
Depth analytics and risk features in one view. |
👉 Sign up → |
COINOTAG recommends • Exchange signup |
🎯 Take control of entries & exits |
Set alerts, define stops, execute consistently. |
👉 Open account → |
COINOTAG recommends • Exchange signup |
🛠️ From idea to execution |
Turn setups into plans with practical order types. |
👉 Join now → |
COINOTAG recommends • Exchange signup |
📋 Trade your plan |
Watchlists and routing that support focus. |
👉 Get started → |
COINOTAG recommends • Exchange signup |
📊 Precision without the noise |
Data‑first workflows for active traders. |
👉 Sign up → |
Conclusion
The biotech sector is showing signs of recovery, with key stocks making significant strides in various areas. Investors should keep an eye on these companies as they continue to innovate and push the boundaries in their respective fields.
COINOTAG recommends • Members‑only research |
📌 Curated setups, clearly explained |
Entry, invalidation, targets, and R:R defined before execution. |
👉 Get access → |
COINOTAG recommends • Members‑only research |
🧠 Data‑led decision making |
Technical + flow + context synthesized into actionable plans. |
👉 Join now → |
COINOTAG recommends • Members‑only research |
🧱 Consistency over hype |
Repeatable rules, realistic expectations, and a calmer mindset. |
👉 Get access → |
COINOTAG recommends • Members‑only research |
🕒 Patience is an edge |
Wait for confirmation and manage risk with checklists. |
👉 Join now → |
COINOTAG recommends • Members‑only research |
💼 Professional mentorship |
Guidance from seasoned traders and structured feedback loops. |
👉 Get access → |
COINOTAG recommends • Members‑only research |
🧮 Track • Review • Improve |
Documented PnL tracking and post‑mortems to accelerate learning. |
👉 Join now → |